Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70340 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Suhong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Sarcopenia, STAT3 Transcription Factor, Wnt Signaling Pathway, Muscle Development. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Special Scientific and Technological Fund Project for the High-quality Development of Healthcare in Lishui District People's Hospital, Jiangsu Province Aged Health Research Project.
Abstract (Originalsprache)
Background
Sarcopenia is a progressive disorder characterized by loss of skeletal muscle mass, strength, and function. Although STAT3 is known to regulate myogenic differentiation, its role in sarcopenia remains unclear.
Methods
STAT3 expression was assessed in skeletal muscle samples from sarcopenia patients and nonsarcopenic controls, as well as aged SAMP8 mice. C2C12 myoblasts were used to investigate the effects of STAT3 on proliferation and myogenic differentiation using gain‐ and loss‐of‐function approaches. The role of the Wnt/β‐catenin pathway was examined using pathway‐specific assays. In vivo, siRNA‐mediated STAT3 knockdown was performed in aged SAMP8 mice to evaluate effects on muscle phenotype and endurance.
Results
STAT3 expression was significantly upregulated in muscle tissues from sarcopenia patients and aged mice, correlating with increased expression of the atrophy marker MuRF‐1. STAT3 levels also rose during C2C12 cell differentiation. STAT3 overexpression suppressed C2C12 proliferation and myogenic differentiation, whereas knockdown enhanced both processes. Mechanistically, STAT3 inhibited Wnt/β‐catenin signaling, reducing the expression of myogenic markers. In vivo, STAT3 silencing in aged mice increased muscle mass, improved treadmill performance, and decreased muscle atrophy markers.
Conclusion
STAT3 impairs myogenic proliferation and differentiation by negatively regulating the Wnt/β‐catenin pathway, contributing to sarcopenia progression. Targeting STAT3 may serve as a promising therapeutic strategy for restoring muscle regeneration and function in sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.
- Department of Orthopedics, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.
ORCID-Profile: Liping Yin
Förderung
- Special Scientific and Technological Fund Project for the High-quality Development of Healthcare in Lishui District People's Hospital
- Jiangsu Province Aged Health Research Project
Zitieren
APA
Zhang, S., Tao, X., Fu, M., Li, Y., Tu, G., Zhang, D., & Yin, L. (2025). Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70340
Vancouver
Zhang S, Tao X, Fu M, Li Y, Tu G, Zhang D, et al. Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70340
BibTeX
@article{Zhang2025,
author = {Zhang, Suhong and Tao, Xin and Fu, Minghui and Li, Yue and Tu, Gongbing and Zhang, Dianfu and Yin, Liping},
title = {Modulation of Wnt/β‐Catenin Signaling by STAT3 Inhibition Restores Myogenic Capacity in Sarcopenia},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70340}
}
EUVIMED